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Abstract
A 44-year-old man consulted an internist because of abnormalities in an upper gastrointestinal series. It showed an
elevated lesion with central depression in the greater curvature of the middle part of the stomach. Upper gastrointestinal
endoscopy showed an elevated lesion with central depression, bridging hold, and no abnormalities of the gastric mucosa
in the greater curvature of the middle part of the stomach. Endoscopic ultrasonography showed a submucosal tumor
derived from the muscle layer of the stomach. Computed tomography showed a 22-mm tumor in the upper part of the
stomach. Integrated position emission tomography/computed tomography (PET/CT) showed an intense tracer
uptake by the tumor. Based on these findings, a gastrointestinal stromal tumor was suspected and laparoscopic
endoscopic cooperative surgery was performed. A histopathological examination showed lymphoplasmacytic infiltration
and fibrosis, and an immunohistochemical analysis showed the infiltration of IgG4-positive lymphoplasmacytic cells. The
probable diagnosis was IgG4-related sclerosing disease of the stomach. We herein describe a rare case of probable IgG4-
related sclerosing disease which presented as a gastric submucosal tumor. PET/CT is a useful imaging technique for the
diagnosis and follow-up of this disease.
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Background
IgG4-related sclerosing disease is a systemic disease charac-
terized by the extensive infiltration of IgG4-positive plasma
cells and lymphocytes in various organs [1]. Although there
are multiple recognized clinical manifestations of IgG4-
related sclerosing disease, including sclerosing cholangitis,
cholecystitis, retroperitoneal fibrosis, interstitial pneumonia,
tubulointerstitial nephritis, and inflammatory pseudotumor
[2], gastric lesions are rare. It has been reported that pos-
ition emission tomography/computed tomography (PET/
CT) is useful for the localized diagnosis of this disease [3].
We present a case of probable IgG4-related sclerosing
disease presenting as a gastric submucosal tumor with
an intense tracer uptake on PET/CT.
Case presentation
A 44-year-old man consulted an internist due to abnor-
malities on an upper gastrointestinal series. He had no
relevant medical history. On examination, he appeared
comfortable, with a temperature of 36.9 °C, blood pressure
152/97 mm Hg, and pulse 79 beats/min. The abdomen
was soft, without tenderness or distension. The remainder
of the examination was unremarkable. The laboratory data
on admission showed a slightly decreased hemoglobin
level of 13.3 g/dL, but the tumor marker levels (CEA,
CA19-9) were almost within the normal limits. Upper
gastrointestinal endoscopy showed an elevated lesion with
central depression, bridging hold, and no abnormalities of
the gastric mucosa in the greater curvature of the middle
part of the stomach (Fig. 1a). Endoscopic ultrasonography
showed that the well-demarcated, heterogeneous echo-
poor mass originated from the muscle layer of the
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stomach (Fig. 1b). An upper gastrointestinal series showed
an elevated lesion with a central depression in the greater
curvature of the middle part of the stomach (Fig. 2). Com-
puted tomography showed a 22-mm solid mass with a
smooth margin and hypervascularity in the gastric wall at
the upper part of the stomach. Integrated PET/CT showed
an intense tracer uptake by the tumor (SUVmax = 6.8)
(Fig. 3). Based on these findings, a gastrointestinal stromal
tumor was suspected. Although the size of the tumor
measured less than 5 cm and did not have clear malignant
views, we judged this case to be a candidate for surgery in
consideration of an intense tracer uptake by PET/CT.
Laparoscopic endoscopic cooperative surgery was per-
formed. First, the tumor location was confirmed at the
greater curvature of the upper part of the stomach, after
which the blood vessels in the excision area around the
tumor were minimally ligated using an ultrasonically acti-
vated device. Next, endoscopic submucosal resection
using endoscopic submucosal dissection (ESD) was per-
formed around the tumor, and the seromuscular layer was
intentionally perforated after three-quarters of the circum-
ference of the excision had been finished. The tip of an
ultrasonically activated device was then inserted into the
perforation, and seromuscular dissection around the
tumor was performed. After the tumor had been resected
and removed, the incision line was closed using laparo-
scopic stapling devices. The operative time was 119 min,
and blood loss was 5 mL.
The resected specimen showed a tumor measuring
20 × 18 mm in diameter, and its divided face was solid
and poorly marginated. A histopathological examination
showed lymphoplasmacytic infiltration and fibrosis
(Fig. 4a), and an immunohistochemical analysis showed
the infiltration of IgG4-positive lymphoplasmacytic cells
(Fig. 4b). The patient was diagnosed with probable
IgG4-related sclerosing disease of the stomach.
The patient made an uneventful recovery and was
discharged on postoperative day 7. He was examined in
a clinic 7 weeks after surgery and was found to have
made a full recovery. Subsequent blood tests revealed
Fig. 1 Upper gastrointestinal endoscopy shows the elevated lesion
in the middle part of the stomach (a). Endoscopic ultrasonography
shows that the tumor is a submucosal tumor derived from the muscle
layer of the stomach (b)
Fig. 2 An upper gastrointestinal series shows an elevated lesion in
the greater curvature of the middle part of the stomach
Fig. 3 PET/CT shows an intense tracer uptake by the tumor in the
upper part of the stomach
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that his serum IgG4 level was 98.1 mg/dL (reference
range 4.8–105 mg/dL); however, the levels had not been
examined prior to resection as an IgG4-related scleros-
ing disease had not been suspected.
Discussion
The gastric manifestations of IgG4-related sclerosing
disease are rare, and PET/CT is a useful imaging tech-
nique for their diagnosis and follow-up. The organ that
is most commonly involved in IgG4-related sclerosing
disease is the pancreas; such involvement is termed
autoimmune pancreatitis (AIP) [1]. AIP is a specific type
of pancreatitis that is thought to have an autoimmune
etiology, and which typically shows the infiltration of
IgG4-positive plasma cells and increased levels of serum
IgG4. IgG4-positive plasma cells may involve not only
the pancreas but also other organs, including the bile
duct, gallbladder, salivary gland, thyroid gland, lungs,
gastrointestinal tract, liver, retroperitoneum, kidney,
prostate, and lymph nodes [4]. In 2003, Kamisawa et al.
proposed a new clinicopathological entity, IgG4-related
sclerosing disease, and suggested that AIP is a pancreatic
lesion that reflects this systemic disease [5].
A diagnosis of IgG4-related disease is definitive in pa-
tients with the following findings: (1) organ enlargement,
mass or nodular lesions, or organ dysfunction; (2) a serum
IgG4 concentration of >135 mg/dL; and (3) histopatho-
logical findings of >10 IgG4 cells/HPF and an IgG4+/IgG+
cell ratio of >40 %. A diagnosis of IgG4-related disease is
possible in patients who fulfill criteria (1) and (2), but with
negative results on histopathology or without a histopath-
ologic examination, whereas a diagnosis of IgG4-related
disease is probable in patients with organ involvement (1)
and in whom the histopathologic criteria are fulfilled,
without an increase in serum IgG4 concentration (2) [4].
Our patient fulfilled criteria (1) and (3); thus, he was di-
agnosed with probable IgG4-related sclerosing disease.
Although the patient’s serum IgG4 levels were normal
after the resection of the submucosal tumor, they could
have been elevated prior to surgery.
There are few reports of IgG4-related sclerosing dis-
ease presenting as a gastric lesion. Rollins et al. reported
a gastric midbody mass which was histologically charac-
terized as an IgG4-related autoimmune fibrosclerosing
pseudotumor [6]. Fujita et al. reported an IgG4-related
gastric ulcer without the main manifestation of auto-
immune pancreatitis [7]. Only one case of IgG4-related
gastric submucosal tumor was described by Murakawa
et al. [8], in a patient who underwent laparoscopic endo-
scopic cooperative surgery. Thus, a gastric submucosal
tumor of IgG4-related sclerosing disease is a rare
manifestation.
Some reports have shown the usefulness of PET/CT
imaging in IgG4-related sclerosing disease [3, 9]. PET/
CT detects the various sclerosing lesions of the whole
body; it is therefore effective for the diagnosis and
follow-up of IgG4-related sclerosing disease. This dis-
ease is characterized by frequent temporal and spatial
recurrence and requires a long-term follow-up. A con-
tinuous whole body search by PET/CT is therefore use-
ful for IgG4-related sclerosing disease patients.
As corticosteroid therapy is effective in IgG4-related
sclerosing disease, it may be considered the first treatment
option. However, a therapeutic diagnosis with corticoster-
oid dosage is not recommended when differentiation with
a malignant tumor is difficult [4]. Therefore, low invasive
surgery such as LECS may be an effective therapy option
for patients who are diagnosed with IgG4-related scleros-
ing disease presenting as a gastric submucosal tumor, such
as the present case, in consideration of the side effects of
corticosteroid dosages.
IgG4-related sclerosing disease is a relatively new disease
concept, and its prognosis has not been well described.
Additional studies of its long-term prognosis are needed.
Fig. 4 The histopathological findings show lymphoplasmacytic
infiltration and fibrosis (×200) (a). Immunohistochemistry findings show
the infiltration of IgG4-positive lymphoplasmacytic cells (×400) (b)
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Conclusions
In summary, we herein described a rare case of probable
IgG4-related sclerosing disease presenting as a gastric sub-
mucosal tumor. PET/CT is a useful imaging technique for
the diagnosis and follow-up of this disease.
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